Skip to main content

Table 4 Cumulative total events averted (all ages) across 43 sub-Saharan African countries, cumulative by 5 year periods for each of the four deliveries: EPI (6–12 weeks), EPI with boosters, expanded routine (6–9 months) and expanded routine with booster

From: The public health impact of malaria vaccine RTS,S in malaria endemic Africa: country-specific predictions using 18 month follow-up Phase III data and simulation models

Events averted

At 5 year followup (thousands)

At 10 year followup (thousands)

At 15 year followup (thousands)

EPI (6-12 weeks)

Uncomplicated

72,723 (47,523-82,667)

148,991 (101,067-176,664)

204,966 (144,404-246,843)

Severe

1,757 (1,223-2,460)

2,608 (1,159-3,943)

3,020 (446-5,414)

Hospitalisations

842 (579-1243)

1,254 (527-1,955)

1476 (220-2,653)

Direct deaths

206 (126-340)

370 (152-576)

482 (149-798)

All deaths

503 (235-647)

1033 (558-1389)

1537 (879-2074)

DALYs

27,075 (12,869-34,801)

55,687 (30,489-74,302)

83,364 (48,162-111,434)

Direct DALYs

11,482 (7,159-18,740)

20,743 (9,307-31,884)

27,642 (9,999-44,694)

EPI with booster

Uncomplicated

97,337 (63,960-110,268)

217,564 (146,622-256,595)

304,518 (212,980-364,054)

Severe

2,441 (1,705-3,333)

4,087 (2,554-5,810)

4,975 (2,225-7,629)

Hospitalisations

1,168 (808-1,655)

1,960 (1,241-2,858)

2,416 (1,113-3,703)

Direct deaths

281 (173-421)

549 (332-823)

731 (384-1,134)

All deaths

622 (320-816)

1334 (771-1674)

1995 (1163-2580)

DALYs

33,413 (17,362-43,664)

71,818 (41,729-89,598)

108,255 (63,463-138,582)

Direct DALYs

15,519 (9,626-23,042)

30,580 (18,902-45,470)

41,714 (23,481-64,095)

Expanded routine (6-9 months)

Uncomplicated

58,230 (38,260-66,696)

119,426 (80,366-141,899)

162,454 (112,002-195,551)

Severe

1,528 (1,054-2,054)

2,560 (1,788-3,490)

3,239 (1,974-4,611)

Hospitalisations

727 (501-1,048)

1224 (836-1,746)

1,565 (890-2,315)

Direct deaths

162 (88-264)

306 (173-488)

406 (217-652)

All deaths

329 (160-448)

684 (375-886)

1008 (500-1293)

DALYs

17,670 (8,749-24,049)

36,881 (20,354-47,826)

54,822 (27,867-70,146)

Direct DALYs

8,955 (4,999-14,537)

17,123 (9,960-26,781)

23,251 (13,386-36,555)

Expanded routine with booster

Uncomplicated

79,300 (52,661-90,279)

179,372 (121,591-211,522)

250,819 (173,421-300,168)

Severe

2,060 (1,455-2,711)

3,744 (2,863-5,028)

4,839 (3,376-6,722)

Hospitalisations

982 (688-1,346)

1,786 (1,332-2,499)

2,323 (1,608-3,335)

Direct deaths

218 (137-324)

439 (305-655)

585 (385-883)

All deaths

418 (228-565)

909 (561-1122)

1333 (811-1634)

DALYs

22,409 (12,370-30,176)

48,905 (30,345-60,518)

72,513 (44,534-88,531)

Direct DALYs

12,012 (7,628-17,739)

24,429 (17,088-35,728)

33,367 (22,551-49,362)